A novel mutation in the N-terminal acting-binding domain of Filamin C protein causing a distal myofibrillar myopathy

Chiara Gemelli, Valeria Prada, Chiara Fiorillo, Sabrina Fabbri, Lorenzo Maggi, Alessandro Geroldi, Sara Gibertini, Paola Mandich, Lucia Trevisan, Paola Fossa, Alberto Stefano Tagliafico, Angelo Schenone, Marina Grandis

Research output: Contribution to journalLetter


Variants in Filamin C (FLNC) gene may cause either cardiomyopathies or different myopathies. We describe a family affected by a distal myopathy with autosomal dominant inheritance. The onset of the disease was in the third decade with gait impairment due to distal leg weakness. Subsequently, the disease progressed with an involvement of proximal lower limbs and hand muscles. Muscle biopsy, performed in one subject,identified relevant myofibrillar abnormalities. We performed a target gene panel testing for myofibrillar myopathies by NGS approach which identified a novel mutation in exon 3 of FLNC gene (c.A664G:p.M222V), within the N-terminal actin-binding (ABD) domain. This variant has been identified in all affected members of the family, thus supporting its pathogenic role. Differently from previously identified variants, our family showed a predominant leg involvement and myofibrillar aggregates, thus further expanding the spectrum of Filamin C related myopathies.

Original languageEnglish
Pages (from-to)75-78
Number of pages4
JournalJournal of the Neurological Sciences
Publication statusPublished - Mar 15 2019



  • Distal myopathy
  • Filamin C
  • FLNC
  • Hereditary myopathy
  • Myofibrillar myopathy
  • NGS

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this